Company Profile
Fresenius SE & Co. KGaA, a health care company provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Its business is organized into Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids
Biosimilar drugs. Its portfolio also includes enteral and parenteral nutrition products, and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers
Provision of medical diagnostics. The company has a strategic collaboration with SAP SE and Avelios Medical GmbH for the development of a cloud-native, modular hospital information system that enables digitalization of clinical and administrative processes with AI integration. Founded in 1912 and based in Bad Homburg vor der Höhe, Germany, Fresenius SE & Co. KGaA was formerly known as Fresenius SE before rebranding in January 2011.